药物交付与再生医学相结合的进展:创新,挑战和未来的前沿
Manoochehr Rasekh1, Muhammad Sohail Arshad2, Zeeshan Ahmad3
1College of Engineering, Design and Physical Sciences, Brunel University of London, Uxbridge UB8 3PH, UK.
Pharmaceutics
|April 26, 2025
概括
本综述探讨了先进的药物输送系统如何增强再生医学的组织修复. 它涵盖生物材料,干细胞和细胞疗法,以改善治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 药物输送系统 药物输送系统
背景情况:
- 药物输送系统和再生医学正在彻底改变医疗保健.
- 创新的策略旨在治疗和修复患病的组织.
- 这些领域的整合提供了增强的治疗潜力.
研究的目的:
- 综合审查近期药物交付与再生医学整合方面的发展和挑战.
- 分析生物材料,局部传递和控制释放系统的进步.
- 探索再生医学方法,包括干细胞和器官再生.
主要方法:
- 关于药物输送技术和再生医学的当前文献的综述.
- 对生物材料设计,局部交付和控制释放系统的分析.
- 检查干细胞疗法,细胞外基质和器官再生策略.
主要成果:
- 药物输送提高了再生医学中的治疗精度和疗效.
- 生物材料,局部传递和受控释放是关键的技术进步.
- 干细胞疗法,细胞外基质和器官再生均取得显著进展.
结论:
- 跨学科的合作对于促进再生医学的发展至关重要.
- 药物输送的尖端创新对于成功的治疗结果至关重要.
- 未来的方向集中在优化细胞输送和细胞-细胞相互作用.
相关概念视频
Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
Drug Delivery Systems: Different Types
406
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
406
Modified-Release Drug Delivery Systems: Overview
236
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
236
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Oral Drug Delivery Systems: Introduction
279
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
279


